Sector Chart Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 18/11/2025 GMT			5-day change	1st Jan Change
5.350 ^USD	+21.59%		+22.15%	+11.69%

05:35am	Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting	CI
11:43pm	Vanda Pharmaceuticals reports positive results for Tradipitant in preventing GLP-1 induced nausea and vomiting	RE

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Finances	EV / Sales	P/E
VANDA PHARMACEUTICALS INC.	260M	-	-	-
ARGENX SE	56.25B
INSMED INCORPORATED	42.1B			-
WUXI APPTEC CO., LTD.	39.23B
BIONTECH SE	24.69B			-
GENMAB A/S	18.89B